The Valley Desk

NCT00988429 · Interventional trial

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Overall registry status Completed

Phase 3

Conditions Partial Epilepsy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov